RedHill Biopharma Ltd. (RDHL)
2.79
0.04 (1.45%)
At close: Mar 28, 2025, 3:56 PM
2.70
-3.23%
After-hours: Mar 28, 2025, 07:58 PM EDT
RedHill Biopharma Ltd. Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 5.57M | 19.97M | 29.47M | 29.3M | 29.02M | 29M | 16.45M | 53.79M | 21.52M | 5.89M | 11.85M | 16.81M | 14.07M |
| Short-Term Investments | 790.04K | 15K | 8.53M | 498K | 18.85M | 24.18M | 29.75M | 12.37M | 36.62M | 17.05M | 262K | 1.55M | 4.58M |
| Long-Term Investments | 147K | 150K | 16.17M | 16.16M | 152K | 140K | 152K | 137K | 134K | 76K | 81K | n/a | n/a |
| Other Long-Term Assets | 34.00 | 150K | 16.17M | 16.16M | -20.73M | -5.62M | 152K | 137K | 134K | 76K | 81K | 75K | 73K |
| Receivables | 3.29M | 37.88M | 32.52M | 29.29M | 1.64M | 1.4M | 2.26M | 492K | 220K | 1.06M | n/a | 84K | 19K |
| Inventory | 4.39M | 11.01M | 14.81M | 6.53M | 1.88M | 769K | 653K | 1.11M | -34.47M | -15.04M | -366K | -951K | -1.49M |
| Other Current Assets | 2.1M | 17.03M | 3.81M | 4.89M | 1.82M | 1.44M | 2.56M | 1.17M | 2.15M | 2.01M | 61K | 114K | 70K |
| Total Current Assets | 16.14M | 85.9M | 89.15M | 70.5M | 53.21M | 56.79M | 51.68M | 67.81M | 60.51M | 26.02M | 12.6M | 18.56M | 18.74M |
| Property-Plant & Equipment | 1.18M | 7.19M | 4.22M | 5.7M | 3.81M | 163K | 230K | 165K | 124K | 146K | 103K | 113K | 132K |
| Goodwill & Intangibles | 5.58M | 65.63M | 71.64M | 87.88M | 16.93M | 5.32M | 5.29M | 6.09M | 6.06M | 2.62M | 1.55M | 1.34M | 1.25M |
| Total Long-Term Assets | 6.91M | 72.97M | 92.04M | 109.75M | 20.89M | 5.62M | 5.67M | 6.4M | 6.32M | 2.84M | 1.74M | 1.53M | 1.45M |
| Total Assets | 23.05M | 158.87M | 181.19M | 180.24M | 74.1M | 62.41M | 57.34M | 74.21M | 66.83M | 28.86M | 14.34M | 20.1M | 20.19M |
| Account Payables | 3.28M | 4.23M | 11.66M | 11.55M | 4.18M | 3.32M | 4.8M | 60K | 119K | 66K | 884K | 313K | 337K |
| Deferred Revenue | n/a | n/a | 37.31M | 41.63M | 5.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 718K | 116.25M | 1.62M | 1.71M | 834K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 15.25M | 76.98M | 68.19M | 59.97M | 5.6M | 7.06M | 7.03M | 5.3M | 5.39M | 1.65M | 1.53M | 765K | 176K |
| Total Current Liabilities | 19.24M | 197.45M | 81.47M | 73.23M | 10.62M | 10.38M | 11.83M | 5.36M | 5.51M | 1.72M | 2.42M | 1.08M | 513K |
| Long-Term Debt | 455K | 6.44M | 86.19M | 85.19M | 2.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.28M | 3.37M | 4.65M | 7.95M | 500K | 844K | 448K | 6.16M | 1.24M | 2.13M | n/a | n/a | 886K |
| Total Long-Term Liabilities | 1.74M | 9.82M | 90.84M | 93.14M | 3.48M | 844K | 448K | 6.16M | 1.24M | 2.13M | n/a | n/a | 886K |
| Total Liabilities | 20.98M | 207.27M | 172.31M | 166.38M | 14.1M | 11.22M | 12.28M | 11.51M | 6.75M | 3.85M | 2.42M | 1.08M | 1.4M |
| Total Debt | 1.17M | 122.69M | 87.81M | 86.9M | 3.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 21.44M | 2.83M | 1.5M | 1.05M | 962K | 767K | 575K | 441K | 343K | 240K | 174K | 143K | 142K |
| Retained Earnings | -407.74M | -433.86M | -367.87M | -280.33M | -208.36M | -169.09M | -132.94M | -89.64M | -61.94M | -42.22M | -33.26M | -23.89M | -15.21M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -341K | -251K | -170K | -126K | -90K | -63K | -39K | -15K |
| Shareholders Equity | 2.07M | -48.4M | 8.88M | 13.86M | 60M | 51.19M | 45.06M | 62.7M | 60.08M | 25.01M | 11.93M | 19.02M | 18.79M |
| Total Investments | 147K | 15K | 8.53M | 498K | 19M | 45.59M | 38.05M | 12.52M | 52.28M | 17.13M | 343K | 1.55M | 4.58M |